Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1941 2
1942 2
1946 1
1947 1
1948 1
1949 2
1950 3
1951 1
1952 1
1953 1
1954 2
1970 1
1973 1
1977 1
1980 1
1986 3
1987 5
1988 3
1989 3
1990 4
1991 3
1993 2
1994 4
1995 4
1997 3
1998 1
1999 1
2001 1
2002 5
2003 1
2004 3
2005 3
2006 4
2008 3
2009 2
2011 2
2012 1
2013 3
2014 3
2016 1
2017 1
2019 1
2020 2
2021 3
2022 6
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer.
Li R, Ferdinand JR, Loudon KW, Bowyer GS, Laidlaw S, Muyas F, Mamanova L, Neves JB, Bolt L, Fasouli ES, Lawson ARJ, Young MD, Hooks Y, Oliver TRW, Butler TM, Armitage JN, Aho T, Riddick ACP, Gnanapragasam V, Welsh SJ, Meyer KB, Warren AY, Tran MGB, Stewart GD, Cortés-Ciriano I, Behjati S, Clatworthy MR, Campbell PJ, Teichmann SA, Mitchell TJ. Li R, et al. Among authors: laidlaw s. Cancer Cell. 2022 Dec 12;40(12):1583-1599.e10. doi: 10.1016/j.ccell.2022.11.001. Epub 2022 Nov 23. Cancer Cell. 2022. PMID: 36423636 Free PMC article.
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Barnes E, Goodyear CS, Willicombe M, Gaskell C, Siebert S, I de Silva T, Murray SM, Rea D, Snowden JA, Carroll M, Pirrie S, Bowden SJ, Dunachie SJ, Richter A, Lim Z, Satsangi J, Cook G, Pope A, Hughes A, Harrison M, Lim SH, Miller P, Klenerman P; PITCH consortium; Basu N, Gilmour A, Irwin S, Meacham G, Marjot T, Dimitriadis S, Kelleher P, Prendecki M, Clarke C, Mortimer P, McIntyre S, Selby R, Meardon N, Nguyen D, Tipton T, Longet S, Laidlaw S, Orchard K, Ireland G; CONSENSUS; Thomas D, Kearns P, Kirkham A, McInnes IB; OCTAVE Collaborative Group. Barnes E, et al. Among authors: laidlaw s. Nat Med. 2023 Jul;29(7):1760-1774. doi: 10.1038/s41591-023-02414-4. Epub 2023 Jul 6. Nat Med. 2023. PMID: 37414897 Free PMC article.
An HCV Vaccine on the Fly.
Laidlaw SM, Dustin LB. Laidlaw SM, et al. J Infect Dis. 2020 Mar 28;221(8):1216-1218. doi: 10.1093/infdis/jiz231. J Infect Dis. 2020. PMID: 31074788 No abstract available.
TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease.
Jones EL, Laidlaw SM, Dustin LB. Jones EL, et al. Among authors: laidlaw sm. Front Immunol. 2021 Sep 6;12:738473. doi: 10.3389/fimmu.2021.738473. eCollection 2021. Front Immunol. 2021. PMID: 34552597 Free PMC article. Review.
Immune control and failure in HCV infection--tipping the balance.
Dustin LB, Cashman SB, Laidlaw SM. Dustin LB, et al. Among authors: laidlaw sm. J Leukoc Biol. 2014 Oct;96(4):535-48. doi: 10.1189/jlb.4RI0214-126R. Epub 2014 Jul 11. J Leukoc Biol. 2014. PMID: 25015956 Free PMC article. Review.
Posttransplant immune-mediated hemolysis.
Sokol RJ, Stamps R, Booker DJ, Scott FM, Laidlaw ST, Vandenberghe EA, Barker HF. Sokol RJ, et al. Among authors: laidlaw st. Transfusion. 2002 Feb;42(2):198-204. doi: 10.1046/j.1537-2995.2002.00026.x. Transfusion. 2002. PMID: 11896335
A prototype lateral flow assay for detection of orthopoxviruses.
Ulaeto DO, Lonsdale SG, Laidlaw SM, Clark GC, Horby P, Carroll MW. Ulaeto DO, et al. Among authors: laidlaw sm. Lancet Infect Dis. 2022 Sep;22(9):1279-1280. doi: 10.1016/S1473-3099(22)00440-6. Epub 2022 Jul 4. Lancet Infect Dis. 2022. PMID: 35798023 No abstract available.
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.
Jackson S, Marshall JL, Mawer A, Lopez-Ramon R, Harris SA, Satti I, Hughes E, Preston-Jones H, Cabrera Puig I, Longet S, Tipton T, Laidlaw S, Doherty RP, Morrison H, Mitchell R, Tanner R, Ateere A, Stylianou E, Wu MS, Fredsgaard-Jones TPW, Breuer J, Rapeport G, Ferreira VM, Gleeson F, Pollard AJ, Carroll M, Catchpole A, Chiu C, McShane H; COV-CHIM01 study team. Jackson S, et al. Among authors: laidlaw s. Lancet Microbe. 2024 Jul;5(7):655-668. doi: 10.1016/S2666-5247(24)00025-9. Epub 2024 May 1. Lancet Microbe. 2024. PMID: 38703782 Free article. Clinical Trial.
105 results